Tuesday, July 14, 2026

Samsung’s 2026 AI Upgrade: How Bixby Makes Home Appliances Smarter

Samsung enhances Bixby for AI appliances, enabling intuitive voice commands and automation across devices for improved user experience.

SK On Locks In a $1.46B U.S. ESS Supply Chain Deal Through 2036: The Tariff-Proof Playbook

SK On accelerates its ESS business in North America with a $1.46 billion supply deal, enhancing local production and reducing reliance on China.

Team USA Wins “Tariff Derby,” Stuns Canada for Olympic Gold

The U.S. men's ice hockey team wins Olympic gold by defeating Canada 2-1 in overtime, ending a 46-year drought.

Tag: Biotech

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Hanmi Pharmaceutical completes acquisition of Aptose Biosciences

Hanmi Pharmaceutical has acquired Aptose Biosciences for $46.7 million, regaining rights to the cancer drug tuspetinib.

Galux: “Beyond Molecular Design, AI Will Run Entire Drug Discovery Process Within 10 Years”

Generative AI in drug discovery is evolving towards agentic AI, which will autonomously manage the entire process, says Galux CEO Seok Chaok.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

[Lillie report] Lilly’s Pacific-facing innovation hub brings K-biotech future to Songdo

Lilly Gateway Labs in San Diego supports early-stage biotechs, expanding to Korea with Samsung Biologics to foster innovation.

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

From Keycaps to World Cup Matches, K-Bio Turns BIO USA Into a Marketing Showcase

The BIO International Convention 2026 showcased innovative marketing and cultural engagement, enhancing the biotech industry's global appeal.

Is BTGEN the Next Big Player in Biopharmaceuticals? Discover Their Unique CDMO Strategy

BTGEN is expanding its CDMO business with National Growth Fund support, focusing on innovative processes instead of competing on scale.

K-Beauty Shines at BIO USA 2026: Discover the Future of Bio-Integrated Skincare!

K-Beauty showcased its biotech innovations at BIO USA 2026 with a pop-up store, attracting global attention and business opportunities.

Supply Chains, M&A and AI: As China Closes In, K-Bio Faces a Critical Window of Opportunity [BIO USA]

Korea's biotech industry faces challenges and opportunities amid global restructuring, emphasizing AI and support for startups at BIO USA 2026.

BIO International Convention 2026: How K-Bio is Shaping the Global Bioindustry

The BIO International Convention 2026 in San Diego showcases biotech innovation, with a focus on AI integration and global partnerships.

Drug Development Is Inherently Unprofitable, Biotech Industry Warns as Delisting Reform Looms

South Korea's biotech sector faces stricter delisting rules, raising concerns over innovation and funding for drug development.

How New Law Will Transform Human-Derived Fat into High-Value Bio-Materials

Human-derived fat, once medical waste, is now a valuable resource for biotech after new legislation allows its recycling for regenerative medicine.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.